Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs M Cash Integrasi Tbk. (MCAS) Price & Performance

UBC Medical Indonesia Tbk.Trade
M Cash Integrasi Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs M Cash Integrasi Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while M Cash Integrasi Tbk. trades at Rp270 (market cap 246.49B, 2.01M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.8× M Cash Integrasi Tbk.'s market cap, and M Cash Integrasi Tbk. is more actively traded (2.01M versus 635.5K). Which is the better fit depends on your goals.

LABSMCAS
Market Cap
691.25B246.49B
Volume
635.5K2.01M
Lot
6.36K20.07K
Turnover
110.15M542.85M
Average Price
173.33270.44
Value
110.15M542.85M
Indicative Equilibrium Price
174270
Indicative Equilibrium Volume
5062

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MCAS
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About M Cash Integrasi Tbk.

PT M Cash Integrasi Tbk (the Company) was established based on Notarial Deed No. 1 of UkonKrisnajaya, S.H., Sp.N. dated June 1, 2010.

Read more on MCAS